Literature DB >> 17096061

Allelic homogeneity in Avellino corneal dystrophy due to a founder effect.

Kaoru Tsujikawa1, Motokazu Tsujikawa2, Hitoshi Watanabe1, Naoyuki Maeda1, Yoshitsugu Inoue1, Takashi Fujikado1, Yasuo Tano1.   

Abstract

Avellino corneal dystrophy (ACD) is a common corneal dystrophy that shows allelic homogeneity, R124H mutation in the transforming growth factor beta-induced (TGFBI) gene. There are distinct phenotypes of homozygous Avellino corneal dystrophy, termed types I and II. To investigate if the difference is caused by a modifier mutation, we sequenced the entire coding region of TGFBI of two types of ACDs. The sequences obtained from each type were identical, and we could not find any nucleotide alternations. Instead, we found seven single nucleotide polymorphisms (SNPs) compared with the normal control. Primer extension analysis revealed that all 14 homozygous patients were homozygotes in each SNP, which meant that all the patients shared the same disease haplotype. Subsequent analysis of 45 heterozygous ACD patients showed strong linkage disequilibrium between disease alleles of each SNP and ACD. These results strongly suggest that the allelic homogeneity of TGFBI associated corneal dystrophies (ACD, lattice corneal dystrophy types I and III, granular corneal dystrophy and Reis-Bucklers dystrophy) might not be caused by mutation hot spots but by the founder effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17096061     DOI: 10.1007/s10038-006-0083-4

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  12 in total

1.  Rapid detection of M1S1 mutations by the protein truncation test.

Authors:  M Tsujikawa; K Tsujikawa; N Maeda; H Watanabe; Y Inoue; Y Mashima; Y Shimomura; Y Tano
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-08       Impact factor: 4.799

2.  Allelic homogeneity due to a founder mutation in Japanese patients with lattice corneal dystrophy type IIIA.

Authors:  Kaoru Tsujikawa; Motokazu Tsujikawa; Shuji Yamamoto; Takashi Fujikado; Yasuo Tano
Journal:  Am J Med Genet       Date:  2002-11-15

3.  Two patterns of opacity in corneal dystrophy caused by the homozygous BIG-H3 R124H mutation.

Authors:  H Watanabe; Y Hashida; K Tsujikawa; M Tsujikawa; N Maeda; Y Inoue; S Yamamoto; Y Tano
Journal:  Am J Ophthalmol       Date:  2001-08       Impact factor: 5.258

4.  Kerato-epithelin mutations in four 5q31-linked corneal dystrophies.

Authors:  F L Munier; E Korvatska; A Djemaï; D Le Paslier; L Zografos; G Pescia; D F Schorderet
Journal:  Nat Genet       Date:  1997-03       Impact factor: 38.330

5.  Identification of the gene responsible for gelatinous drop-like corneal dystrophy.

Authors:  M Tsujikawa; H Kurahashi; T Tanaka; K Nishida; Y Shimomura; Y Tano; Y Nakamura
Journal:  Nat Genet       Date:  1999-04       Impact factor: 38.330

6.  BIGH3 mutation spectrum in corneal dystrophies.

Authors:  Francis L Munier; Beatrice E Frueh; Philippe Othenin-Girard; Sylvie Uffer; Pascal Cousin; Ming X Wang; Elise Héon; Graeme C M Black; Maria A Blasi; Emilio Balestrazzi; Birgit Lorenz; Rafael Escoto; Rafael Barraquer; Maria Hoeltzenbein; Balder Gloor; Maurizio Fossarello; Arun D Singh; Yvan Arsenijevic; Léonidas Zografos; Daniel F Schorderet
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

7.  Severe corneal dystrophy phenotype caused by homozygous R124H keratoepithelin mutations.

Authors:  M Okada; S Yamamoto; Y Inoue; H Watanabe; N Maeda; Y Shimomura; Y Ishii; Y Tano
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-09       Impact factor: 4.799

8.  Clinically atypical granular corneal dystrophy with pathologic features of lattice-like amyloid deposits. A study of these families.

Authors:  R Folberg; E Alfonso; J O Croxatto; N G Driezen; N Panjwani; P R Laibson; S A Boruchoff; J Baum; E S Malbran; R Fernandez-Meijide
Journal:  Ophthalmology       Date:  1988-01       Impact factor: 12.079

9.  Avellino corneal dystrophy. Clinical manifestations and natural history.

Authors:  E J Holland; S M Daya; E M Stone; R Folberg; A A Dobler; J D Cameron; D J Doughman
Journal:  Ophthalmology       Date:  1992-10       Impact factor: 12.079

10.  Phenotypic variation in combined granular-lattice (Avellino) corneal dystrophy.

Authors:  G O Rosenwasser; B M Sucheski; N Rosa; B Pastena; A Sebastiani; J W Sassani; H D Perry
Journal:  Arch Ophthalmol       Date:  1993-11
View more
  5 in total

1.  Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation.

Authors:  Ana B Rodríguez-Martínez; Miguel A Alfonso-Sánchez; José A Peña; Raquel Sánchez-Valle; Inga Zerr; Sabina Capellari; Miguel Calero; Juan J Zarranz; Marian M de Pancorbo
Journal:  Neurogenetics       Date:  2008-03-18       Impact factor: 2.660

2.  Pathogenic mutations of TGFBI and CHST6 genes in Chinese patients with Avellino, lattice, and macular corneal dystrophies.

Authors:  Ya-nan Huo; Yu-feng Yao; Ping Yu
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

3.  Granular and lattice deposits in corneal dystrophy caused by R124C mutation of TGFBIp.

Authors:  Dhara A Patel; Shu-Hong Chang; George J Harocopos; Smita C Vora; Diep Huu Thang; Andrew J W Huang
Journal:  Cornea       Date:  2010-11       Impact factor: 2.651

4.  Two novel mutations of TACSTD2 found in three Japanese gelatinous drop-like corneal dystrophy families with their aberrant subcellular localization.

Authors:  Mina Nakatsukasa; Satoshi Kawasaki; Kenta Yamasaki; Hideki Fukuoka; Akira Matsuda; Kohji Nishida; Shigeru Kinoshita
Journal:  Mol Vis       Date:  2011-04-19       Impact factor: 2.367

5.  Evaluation of the Genetic Variation Spectrum Related to Corneal Dystrophy in a Large Cohort.

Authors:  Wei Li; Ning Qu; Jian-Kang Li; Yu-Xin Li; Dong-Ming Han; Yi-Xi Chen; Le Tian; Kang Shao; Wen Yang; Zhuo-Shi Wang; Xuan Chen; Xiao-Ying Jin; Zi-Wei Wang; Chen Liang; Wei-Ping Qian; Lu-Sheng Wang; Wei He
Journal:  Front Cell Dev Biol       Date:  2021-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.